Search articles in Company Focus
Filter Articles
Open filtersClose filters
Sections
- All (3,808 articles)
- Pharma Events (46 articles)
- For Recruiters (280 articles)
- Careers Events (7 articles)
- Partners (3 articles)
- News (3,179 articles)
- Careers Advice (307 articles)
- Company Focus (207 articles)
- Company Career Hubs (1 article)
- Pharma Training (7 articles)
- 25 Years of PharmiWeb (13 articles)
- DE&I (3 articles)
Found 207 articles
About Bioxodes
- 12 Feb 2025
Bioxodes is a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of thrombotic and inflammatory diseases. Since its founding in 2013, Bioxodes has developed its lead asset BIOX-101, a first-in-class drug candidate aimed at patients with thrombo-inflammatory disease.
About OPEN Health
- 11 Feb 2025
OPEN Health unites deep scientific knowledge with wide-ranging specialist expertise to unlock possibilities that improve health outcomes and patient well-being. Working in partnership with our clients, we embrace our different perspectives and strengths to deliver fresh thinking and solutions that make a difference.
About Aplagon
- 10 Feb 2025
Aplagon is a clinical stage biopharmaceutical company developing a first-in-class therapeutic APAC for treating thrombo-inflammatory diseases.
About Enduro Genetics
- 7 Feb 2025
Enduro Genetics is a deeptech company transforming biomanufacturing by solving the challenge of microbial productivity. Its patented synthetic addiction technology, Enduro Sense, boosts yields, reduces costs and waste, and enables scalable, sustainable production across biochemicals, alternative proteins, pharmaceuticals, and more.
About Dxcover Limited
- 5 Feb 2025
Dxcover’s proprietary PANAROMIC™ Platform shines light on the difficulty of early cancer diagnosis. By utilizing a multiomic spectral analysis (MOSA-Dx™) approach to detect cancer, the platform can detect the presence of disease with minute volumes of liquid sample, with a turnaround time of one day.
-
About Tepsivo
- 4 Feb 2025
Tepsivo is a specialized services provider offering pharmacovigilance full service, powered by inhouse-built software, to pharmaceutical and biotech companies globally.
About Vect-Horus
- 3 Feb 2025
Vect-Horus designs and develops vectors that facilitate targeting and delivery of therapeutic or imaging agents to organs, including the brain, and to tumors. Founded in 2005, Vect-Horus is a spin-off of the Institute for Neurophysiopathology (INP, UMR7051, CNRS and Aix Marseille University), formerly headed by Dr Michel Khrestchatisky, co-founder of the company.
About Commit Biologics
- 31 Jan 2025
Commit Biologics (Commit) is a pioneer in activating the complement system to kill specific target cells, with applications in cancers and autoimmune diseases.
About ENA Respiratory
- 30 Jan 2025
ENA Respiratory is a clinical-stage pharmaceutical company tackling serious respiratory viral infections through the development of host defense immune enhancers which locally prime and boost the body’s innate immune response – the natural first line of defence against invading pathogens.
About Synaffix B.V.
- 15 Jan 2025
Synaffix B.V. is a biotechnology company that enables ADC product candidates using its clinical-stage, site-specific ADC technology platform based on GlycoConnect®, HydraSpace® and toxSYN® technologies, that together enable any company with an antibody to develop proprietary best-in-class ADC products under a single license from Synaffix.
About Gaelic Laboratories
- 14 Jan 2025
Gaelic Laboratories is a world-class manufacturer of Beta-Lactam (penicillin) products, with newly equipped laboratories offering rapid and cost-effective release testing. Our site in Ireland is licenced by the HPRA.
About Genevant Sciences
- 13 Jan 2025
Genevant Sciences is a leading nucleic acid delivery company with world-class platforms, a robust and expansive lipid nanoparticle (LNP) patent portfolio, and decades of experience and expertise in nucleic acid drug delivery and development.
About Epitopea
- 10 Jan 2025
Epitopea is a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies for use in hard-to-treat cancers by targeting a new class of untapped tumor-specific antigens, which are known as Cryptigen™ TSAs, that are broadly shared across multiple patients with the same tumor type.
PharmiWeb.Jobs Welcomes eTeam Inc
- 16 Dec 2024
eTeam was formed in 1999 with the goal of becoming the company of choice for clients, talent and staffing professionals. Today, we’re one of the fastest-growing global companies and ranked as one of the best companies to work for by Staffing Industry Analysts.
About Nonacus
- 31 Oct 2024
Nonacus is a leading provider of genetic testing products headquartered in Birmingham, UK. Collaborating closely with scientists and clinicians, the company is developing a comprehensive precision oncology workflow including support for primary tumor and liquid biopsy analysis with the ultimate goal of creating a world where early cancer diagnosis, detection and management is simple and universally available.
Breaking new ground: Why CNX Therapeutics' Nordic journey matters
- 29 Oct 2024
When I stepped into my new role this summer at CNX Therapeutics leading commercial activities in the Nordics, I knew I was joining something special. But today, as I sit in CNX’s Copenhagen office, reflecting on my first 100 days in the role and the company’s wider plans for the region, I can't help but feel an extra surge of excitement.
About Angelini Pharma
- 28 Oct 2024
Angelini Pharma is an international pharmaceutical company, part of the privately owned multi-business Angelini Industries. The Company researches, develops and commercializes health solutions with a focus on the areas of Brain Health, including Mental Health and Epilepsy, and Consumer Health.
About ProQR Therapeutics
- 25 Oct 2024
ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA therapies. ProQR is pioneering a next-generation RNA technology called Axiomer™.
About Akiram Therapeutics
- 24 Oct 2024
Akiram Therapeutics is a Swedish biotech company focused on the development of targeted radioimmunotherapy for cancer, which is based on a proprietary antibody targeting the cancer marker CD44v6 combined with a radiation component.
About Wobble Genomics
- 23 Oct 2024
Wobble Genomics is an innovative healthcare and biotechnology company at the forefront of long-read RNA sequencing whose mission is to understand cancer in a new way. The company was founded by Dr Richard Kuo during his PHD at the home of genomics, The Roslin Institute, at The University of Edinburgh.